Literature DB >> 15465612

Prevalence of anti-heat shock protein antibodies in cerebrospinal fluids of patients with Guillain-Barré syndrome.

Kazumi Yonekura1, Shin-ichi Yokota, Shingo Tanaka, Hiroshi Kubota, Nobuhiro Fujii, Hiroyuki Matsumoto, Susumu Chiba.   

Abstract

We examined antibodies against 10 heat shock proteins (HSPs) in cerebrospinal fluids (CSF) and sera from patients with Guillain-Barré syndrome (GBS). Significantly higher IgG antibody titers against HSP27, HSP60, HSP70 and HSP90 family, including mycobacterial HSP65 and Escherichia coli GroEL, were found in CSF from GBS patients as compared with motor neuron disease. Serum IgG antibodies against each HSP showed no difference between GBS patients and normal controls. GBS seems to be induced by reactive autoimmune responses frequently triggered by infections. The CSF antibodies against HSPs may modify the immune responses and/or cell-protective functions of HSPs in the pathophysiology of GBS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15465612     DOI: 10.1016/j.jneuroim.2004.07.017

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  11 in total

1.  Intrathecal anti-alphaB-crystallin IgG antibody responses: potential inflammatory markers in Guillain-Barré syndrome.

Authors:  Julia Wanschitz; Rainer Ehling; Wolfgang N Löscher; Betinna Künz; Florian Deisenhammer; Jens Kuhle; Herbert Budka; Markus Reindl; Thomas Berger
Journal:  J Neurol       Date:  2008-07-11       Impact factor: 4.849

Review 2.  Antiganglioside antibodies and their pathophysiological effects on Guillain-Barré syndrome and related disorders--a review.

Authors:  Kenichi Kaida; Toshio Ariga; Robert K Yu
Journal:  Glycobiology       Date:  2009-02-24       Impact factor: 4.313

3.  SARS-CoV-2 and Guillain-Barré syndrome: molecular mimicry with human heat shock proteins as potential pathogenic mechanism.

Authors:  Guglielmo Lucchese; Agnes Flöel
Journal:  Cell Stress Chaperones       Date:  2020-07-29       Impact factor: 3.667

4.  High prevalence of Campylobacter jejuni CC21 and CC257 clonal complexes in children with gastroenteritis in Tehran, Iran.

Authors:  Mahnaz Sarhangi; Bita Bakhshi; Shahin Najar Peeraeyeh
Journal:  BMC Infect Dis       Date:  2021-01-23       Impact factor: 3.090

5.  Reply: Guillain-Barré syndrome, SARS-CoV-2 and molecular mimicry and Ongoing challenges in unravelling the association between COVID-19 and Guillain-Barré syndrome and Unclear association between COVID-19 and Guillain-Barré syndrome and Currently available data regarding the potential association between COVID-19 and Guillain-Barre syndrome.

Authors:  Michael P Lunn; Aisling C Carr; Stephen Keddie; Julia Pakpoor; Menelaos Pipis; Hugh J Willison
Journal:  Brain       Date:  2021-04-03       Impact factor: 13.501

Review 6.  Novel Immunological and Therapeutic Insights in Guillain-Barré Syndrome and CIDP.

Authors:  Luis Querol; Cinta Lleixà
Journal:  Neurotherapeutics       Date:  2021-09-21       Impact factor: 7.620

Review 7.  The Pathophysiological Role of Heat Shock Response in Autoimmunity: A Literature Review.

Authors:  Ariadni Androvitsanea; Kostas Stylianou; Eleni Drosataki; Ioannis Petrakis
Journal:  Cells       Date:  2021-10-01       Impact factor: 6.600

Review 8.  Heat shock proteins: Biological functions, pathological roles, and therapeutic opportunities.

Authors:  Chen Hu; Jing Yang; Ziping Qi; Hong Wu; Beilei Wang; Fengming Zou; Husheng Mei; Jing Liu; Wenchao Wang; Qingsong Liu
Journal:  MedComm (2020)       Date:  2022-08-02

Review 9.  SARS-CoV-2 Infection and Guillain-Barré Syndrome: A Review on Potential Pathogenic Mechanisms.

Authors:  Shahrzad Shoraka; Maria Lucia Brito Ferreira; Seyed Reza Mohebbi; Amir Ghaemi
Journal:  Front Immunol       Date:  2021-05-10       Impact factor: 7.561

10.  Zika E Glycan Loop Region and Guillain-Barré Syndrome-Related Proteins: A Possible Molecular Mimicry to Be Taken in Account for Vaccine Development.

Authors:  Grégorie Lebeau; Etienne Frumence; Jonathan Turpin; Floran Begue; Jean-Jacques Hoarau; Gilles Gadea; Pascale Krejbich-Trotot; Philippe Desprès; Wildriss Viranaicken
Journal:  Vaccines (Basel)       Date:  2021-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.